Conference Coverage

Do not miss cannabis use in gastroparesis patients


 

REPORTING FROM DIGESTIVE DISEASES: NEW ADVANCES

PHILADELPHIA – When evaluating potential causes of gastroparesis, cannabis use is a “do not miss” diagnosis that is easy to overlook and likely on the rise, according to Anthony J. Lembo, MD.

“This is not an infrequent problem, and I’ve even missed it a couple of times,” said Dr. Lembo, director of the GI Motility Laboratory at Beth Israel Deaconess Medical Center, Boston.

The rate of U.S. emergency department visits for vomiting with cannabis use disorder rose from 2.3 to 13.3 per 100,000 visits from 2006 to 2013, according to an analysis recently published by Dr. Lembo and colleagues (J Clin Gastroenterol. 2017 Oct 31. doi: 10.1097/MCG.0000000000000944).

The study showed that men between 20 and 29 years were the most common group presenting for vomiting with cannabis use disorder.

Pages

Recommended Reading

Gut grief
Clinician Reviews
AGA Guideline: Use goal-directed fluid therapy, early oral feeding in acute pancreatitis
Clinician Reviews
VIDEO: No short-term link found between PPIs, myocardial infarction
Clinician Reviews
Ulcerative colitis is disabling over time
Clinician Reviews
Colorectal cancer deaths projected for 2018
Clinician Reviews
New C. difficile guidelines recommend fecal microbiota transplants
Clinician Reviews
Guidelines update best practices for hemorrhoid treatment
Clinician Reviews
NASH rapidly overtaking hepatitis C as cause of liver cancer
Clinician Reviews
Bloating. Flatulence. Think SIBO
Clinician Reviews
New study establishes IBD severity index
Clinician Reviews